Jump to content
IndiaDivine.org

Bird Flu Vaccines Lose Their Strength

Rate this topic


Guest guest

Recommended Posts

" inoculation by WHO knows for immunity " theory You may have determined, like

me, that this is faulty; add to that this fact ... " quality control " in the

industry that brought us VIOXX/Thimerosal-----ethyl mercuri thiosalicylic

acid//etc sucks.

Bird Flu Vaccines Lose Their Strength Main Category: Bird Flu / Avian Flu

News

Article 20 Nov 2006 - 14:00pm (PST)

| email this article | printer friendly | view or write opinions |

 

http://www.medicalnewstoday.com/healthnews.php?newsid=57122 & nfid=nl

The initial doses of bird flu vaccines that were stockpiled by US authorities

are less effective now - they lose their strength over time. As the vaccines

have a shorter 'shelf-life' than was first expected, it is possible that the US

stockpile would now cover one million fewer people than previously thought.

 

In other words - as the vaccines have a shorter shelf-life than we had

previously thought, many of the first ones that were bought may now not be so

good.

(Shelf life = How long a drug can be kept/stored before it has to be thrown

away. A bit like 'expiry date' on foods. If a drug has a two-year shelf life and

was made on 1 January, 2007, it must be discarded by the end of 2008.)

 

Authorities may have to re-think their contingency plans. It was first thought

that by having large stocks of H5N1 vaccines, a nation would be better prepared

against a possible pandemic by vaccinating health workers, key personnel and

other high-risk groups.

 

Even so, authorities stressed that the loss of strength is gradual, not total.

It does not mean that the strength of the oldest vaccines in stock have gone

down from 100 to zero.

 

Novartis Wins Contract To Top Up USA H5N1 Vaccine Stockpile

 

Novartis has been awarded a $40.95 million contract to top up the USA's bird flu

vaccine stockpile. US authorities aim to have enough vaccines to cover 20

million people. Last year Novartis was awarded a $62.5 million contract.

 

The pre-pandemic egg-based vaccine will be manufactured by Novartis in 2007 in

Liverpool, UK.

 

Written by: Christian Nordqvist

Editor: Medical News Today

 

AND.. b-t-w-- if interested

November 27 - December 3 Is National Influenza Vaccination Week ... Time To

Get Your Flu Vaccination!

http://www.medicalnewstoday.com/medicalnews.php?newsid=56574 & nfid=nl

 

 

 

Sponsored Link

 

$200,000 mortgage for $660/mo - 30/15 yr fixed, reduce debt, home equity -

Click now for info

 

 

Link to comment
Share on other sites

Join the conversation

You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.

Guest
Reply to this topic...

×   Pasted as rich text.   Paste as plain text instead

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.

Loading...
×
×
  • Create New...